{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:57:02Z","timestamp":1756461422028,"version":"3.44.0"},"reference-count":16,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2014,3,25]]},"abstract":"<jats:p>This report describes the case of a 44-year-old Caucasian woman of Northern European descent with a medical history of pyoderma gangrenosum, chronic abdominal pain and erythema nodosum which required intermittent use of high-dose steroids that failed to improve her symptoms. The patient was initially diagnosed with Crohn's disease and most recently with sclerosing mesenteritis. She presented to the hospital with worsening abdominal pain. She was found to have recurrent painful aphthous oral, genital and perianal ulcers and a clinical diagnosis of Beh\u00e7et's disease was made. Her hospitalisation was complicated by haemoptysis, and bronchoscopy revealed alveolar haemorrhage. Treatment was initiated with three\u2005days of pulse intravenous solumedrol 1\u2005g\/day and cyclophosphamide at 700\u2005mg\/m<jats:sup>2<\/jats:sup>. The case had a favourable outcome despite the initial diagnostic challenges. This report emphasises that systemic diseases, including Beh\u00e7et's disease, can have variable presentations and can be frequently misdiagnosed.<\/jats:p>","DOI":"10.1136\/bcr-2013-202919","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T05:47:51Z","timestamp":1397886471000},"page":"bcr2013202919","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["The great masquerader: Beh\u00e7et's disease"],"prefix":"10.1136","volume":"2014","author":[{"given":"Edra","family":"Nordstrom","sequence":"first","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis, Indiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, IU Health University at Indianapolis, Indiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,4,19]]},"reference":[{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.11.996"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.22.1.36"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.3","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200301000-00006"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.4","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12107"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.5","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199301000-00008"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-6-791"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.7","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-6-199803150-00004"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002013220501"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.10","unstructured":"Assaad-Khalil SH . Low-dose cyclosporin in Beh\u00e7et's disease: follow-up controlled study with emphasis on extraocular manifestations and neuro-Beh\u00e7et's disease. In: O'DuVy JD Kokmen E . eds. Beh\u00e7et's disease: basic and clinical aspects. New York: Marcel Dekker, 1991:603\u201312."},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.11","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.467"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.12","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0542-4"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem034"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.14","first-page":"98","article-title":"Short-term trial of etanercept in Beh\u00e7et's disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.15","first-page":"S320","article-title":"Pulse cyclophosphamide (PCP) for ocular lesions of Beh\u00e7et's disease: double blind crossover study","volume":"42","author":"Davatchi","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2025082800214585000_2014.apr19_1.bcr2013202919.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.080432"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-202919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:21:52Z","timestamp":1756365712000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-202919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,19]]},"references-count":16,"alternative-id":["10.1136\/bcr-2013-202919"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-202919","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2014,4,19]]}}}